Michaelis-Menten Enzyme Velocity Solver

Michaelis-Menten Enzyme Velocity Solver: Saturation Kinetics, Lineweaver-Burk & Catalytic Efficiency Guide

1. Introduction

In biochemistry, pharmacology, molecular medicine, and industrial biotechnology, enzymes are the biological catalysts that accelerate chemical reactions by factors of $10^6$ to $10^{17}$. Understanding the relationship between substrate concentration ($[S]$) and initial reaction velocity ($v_0$) is essential for determining enzyme mechanism, evaluating drug inhibitor potency, and engineering biocatalysts for green chemistry.

The foundational mathematical framework governing enzyme catalysis is the Michaelis-Menten Model, formulated by German biochemist Leonor Michaelis and Canadian physician Maud Menten in 1913, and subsequently refined under steady-state assumptions by G.E. Briggs and J.B.S. Haldane in 1925.

Unlike uncatalyzed bimolecular reactions that scale linearly with reactant concentrations, enzyme-catalyzed reactions exhibit hyperbolic saturation kinetics. At low substrate concentrations, reaction rate is directly proportional to $[S]$ (first-order kinetics). As substrate concentration increases, active sites become progressively occupied until the enzyme achieves maximum catalytic velocity ($V_{\max}$), where reaction rate becomes independent of $[S]$ (zero-order kinetics).

In clinical toxicology, Michaelis-Menten kinetics explain why administering Ethanol or Fomepizole successfully treats lethal Methanol poisoning via competitive active-site occupancy. In drug discovery, kinetic analysis determines whether candidate molecules act as competitive, non-competitive, or uncompetitive inhibitors.

How is the Michaelis constant ($K_m$) derived from rate constants? How does the Lineweaver-Burk double reciprocal plot linearize experimental data? What defines an enzyme operating at the theoretical limit of "catalytic perfection"?

This comprehensive guide details the mathematical formulas, steady-state derivations, inhibition mechanics, and clinical case studies governing Michaelis-Menten enzyme kinetics.

flowchart LR
    SUBSTRATE["🧪 Enzyme (E) + Substrate (S)
Substrate Concentration [S]
Active Site Association (k1)"] --> COMPLEX["🔒 ES Transition Complex
Steady-State Equilibrium (d[ES]/dt = 0)
Michaelis Constant (Km)"]
    COMPLEX --> PRODUCT["⚡ Catalytic Turnover (kcat)
Enzyme (E) + Product (P)
Max Velocity (Vmax)"]
    PRODUCT --> PHARMA["💊 Clinical & Drug Applications
Statin Inhibition, Toxicology Antidotes & Biocatalysis"]

2. Definitions

2.1 Simple Everyday Definition

The Michaelis-Menten Equation describes how fast an enzyme converts a chemical substrate into product as you feed it more substrate, eventually reaching a maximum speed limit ($V_{\max}$) when all enzyme active sites are working at full capacity.

2.2 Formal Technical Definition

The Michaelis-Menten Equation relates the Initial Reaction Velocity ($v_0$) to the Substrate Concentration ($[S]$) under the Briggs-Haldane Steady-State Assumption ($\frac{d[ES]}{dt} = 0$):

Where:

• $v_0$ is the Initial Reaction Velocity ($\mu\text{M/min}$ or $\text{mol}\cdot\text{L}^{-1}\text{s}^{-1}$).

• $V_{\max}$ is the Maximum Catalytic Velocity achieved when all enzyme active sites are saturated with substrate ($V_{\max} = k_{\text{cat}} [E]_T$).

• $[S]$ is the Substrate Concentration ($\text{mM}$ or $\mu\text{M}$).

• $K_m$ is the Michaelis Constant ($\text{mM}$ or $\mu\text{M}$), defined as the substrate concentration at which the reaction velocity is exactly half of $V_{\max}$ ($v_0 = \frac{V_{\max}}{2}$).

• Turnover Number ($k_{\text{cat}}$): The number of substrate molecules converted into product per enzyme active site per unit time ($\text{s}^{-1}$):
  $$\mathbf{k_{\text{cat}} = \frac{V_{\max}}{[E]_T}}$$

• Catalytic Efficiency ($\frac{k_{\text{cat}}}{K_m}$): The second-order rate constant measuring enzyme performance at low physiological substrate concentrations ($\text{M}^{-1}\text{s}^{-1}$).

2.3 Vivid Real-World Analogies

3. History & Scientific Milestones

The elucidation of enzyme kinetics provided the quantitative foundation for modern biochemistry and molecular pharmacology.

flowchart TD
    H1["📅 1902: Victor Henri
Proposes that enzyme catalysis proceeds via an intermediate Enzyme-Substrate (ES) complex"] --> H2["📅 1913: Leonor Michaelis & Maud Menten
Derive quantitative mathematical saturation equation using yeast Invertase"]
    H2 --> H3["📅 1925: G.E. Briggs & J.B.S. Haldane
Introduce the Steady-State Assumption (d[ES]/dt = 0), establishing modern Km"]
    H3 --> H4["📅 1934: Hans Lineweaver & Dean Burk
Linearize hyperbolic data into the Double Reciprocal Plot (1/v vs. 1/[S])"]
    H4 --> H5["📅 1976: Jeremy Knowles & John Albery
Define the physical diffusion limit (10⁸ - 10⁹ M⁻¹s⁻¹) as 'Catalytic Perfection'"]

• Victor Henri (1902): First hypothesized that enzymes physically bind their substrates to form a transient Enzyme-Substrate ($\text{ES}$) complex prior to product release.

• Leonor Michaelis & Maud Menten (1913): Published Die Kinetik der Invertinwirkung, measuring the hydrolysis of sucrose by yeast invertase and formulating the first mathematical equation relating substrate concentration to initial catalytic rate.

• G.E. Briggs & J.B.S. Haldane (1925): Replaced the rapid-equilibrium assumption with the Quasi-Steady-State Assumption ($\text{QSSA}$), proving that the concentration of the intermediate $\text{ES}$ complex remains constant during the initial velocity phase:
  $$K_m = \frac{k_{-1} + k_{\text{cat}}}{k_1}$$

• Hans Lineweaver & Dean Burk (1934): Published the Double Reciprocal Plot, allowing exact graphical determination of $V_{\max}$ and $K_m$ prior to computer non-linear regression.

• Jeremy R. Knowles & W. John Albery (1976): Demonstrated that enzymes like Triosephosphate Isomerase (TIM) and Carbonic Anhydrase have evolved to the upper thermodynamic diffusion limit ($10^8\text{-}10^9\text{ M}^{-1}\text{s}^{-1}$), achieving "Catalytic Perfection".

4. Core Concepts & Biochemical Mechanisms

graph TD
    MECH["⚙️ The 3 Fundamental Concepts of Michaelis-Menten Catalysis"]
    
    MECH --> REACTION["1. Reaction Coordinate & Steady State
E + S ⇄ (k1 / k-1) ⇄ ES → (kcat) → E + P
• Steady-State: d[ES]/dt = 0
• Substrate in vast excess: [S] >> [E]total"]
    MECH --> SATURATION["2. Hyperbolic Saturation Kinetics
• Low [S] << Km: Linear first-order (v0 ≈ (Vmax/Km)·[S])
• [S] = Km: Half-maximal velocity (v0 = Vmax / 2)
• High [S] >> Km: Zero-order plateau (v0 ≈ Vmax)"]
    MECH --> INHIBITION["3. Reversible Enzyme Inhibition
• Competitive: Binds E active site (Km↑, Vmax constant)
• Non-Competitive: Binds allosteric site (Km constant, Vmax↓)
• Uncompetitive: Binds ES complex only (Km↓, Vmax↓)"]

4.1 The Reaction Coordinate & Steady-State Derivation

An enzyme ($E$) binds substrate ($S$) reversibly to form an enzyme-substrate complex ($ES$), which irreversibly decomposes into free enzyme ($E$) and product ($P$):

• Rate of $ES$ Formation: $\frac{d[ES]}{dt} = k_1 [E] [S]$

• Rate of $ES$ Breakdown: $-\frac{d[ES]}{dt} = (k_{-1} + k_{\text{cat}}) [ES]$

• Steady-State Condition: $k_1 [E] [S] = (k_{-1} + k_{\text{cat}}) [ES] \implies \frac{[E] [S]}{[ES]} = \frac{k_{-1} + k_{\text{cat}}}{k_1} = \mathbf{K_m}$

• Substituting total enzyme $[E]_T = [E] + [ES]$ and initial velocity $v_0 = k_{\text{cat}} [ES]$ yields:
  $$\mathbf{v_0 = \frac{k_{\text{cat}} [E]_T [S]}{K_m + [S]} = \frac{V_{\max} [S]}{K_m + [S]}}$$

4.2 Significance of $K_m$, $k_{\text{cat}}$, and Catalytic Efficiency

• $K_m$ (Michaelis Constant): Measures substrate concentration needed for 50% active-site saturation. A low $K_m$ signifies high affinity (tight binding); a high $K_m$ signifies low affinity (weak binding).

• $k_{\text{cat}}$ (Turnover Number): The maximum number of catalytic cycles per active site per second ($V_{\max} / [E]_T$).

• Catalytic Efficiency ($\frac{k_{\text{cat}}}{K_m}$): Evaluates how effectively the enzyme captures and turns over substrate at trace physiological concentrations ($[S] \ll K_m$). The upper physical limit is governed by the rate of aqueous diffusion ($10^8\text{-}10^9\text{ M}^{-1}\text{s}^{-1}$).

5. Formulas & Mathematical Derivations

5.1 Michaelis-Menten Velocity Equation

5.2 Lineweaver-Burk Double Reciprocal Equation

Taking the reciprocal of both sides of the Michaelis-Menten equation:

• $y\text{-intercept}$: $\frac{1}{V_{\max}}$

• $x\text{-intercept}$: $-\frac{1}{K_m}$

• Slope: $\frac{K_m}{V_{\max}}$

5.3 Active Site Fractional Saturation ($\theta$)

5.4 Catalytic Efficiency & Turnover

5.5 Reversible Enzyme Inhibition Equations

Where $K_i$ is the dissociation constant of the inhibitor from the enzyme: $\alpha = 1 + \frac{[I]}{K_i}$.

5.6 Variable Reference Table

6. Step-by-Step Computational Walkthrough

Let us calculate the kinetic profile for a recombinant lactase assay:

• Substrate concentration (Lactose): $[S] = 5.0\text{ mM}$
• Maximum velocity: $V_{\max} = 100\text{ }\mu\text{M/min}$
• Michaelis constant: $K_m = 2.0\text{ mM}$
• Total enzyme concentration: $[E]_T = 0.5\text{ }\mu\text{M}$

flowchart TD
    STEP1["Step 1: Calculate Initial Reaction Velocity (v0)
v0 = (Vmax × [S]) / (Km + [S]) = (100 × 5.0) / (2.0 + 5.0) = 71.43 μM/min"] --> STEP2["Step 2: Solve Fractional Active Site Saturation (θ)
θ = [S] / (Km + [S]) = 5.0 / 7.0 = 71.43% Saturation"]
    STEP2 --> STEP3["Step 3: Solve Lineweaver-Burk Parameters
Slope = Km/Vmax = 2.0/100 = 0.020 min
y-int = 1/Vmax = 0.010 μM⁻¹·min | x-int = -1/Km = -0.50 mM⁻¹"]
    STEP3 --> STEP4["Step 4: Calculate Turnover Number (kcat)
Vmax in μM/s = 100 / 60 = 1.6667 μM/s
kcat = 1.6667 / 0.5 μM = 3.33 s⁻¹"]
    STEP4 --> STEP5["Step 5: Solve Catalytic Efficiency (kcat / Km)
Km in Molar = 2.0 × 10⁻³ M
Efficiency = 3.33 / (2.0 × 10⁻³) = 1.67 × 10³ M⁻¹s⁻¹"]

1. Step 1: Initial Velocity ($v_0$):
   $$v_0 = \frac{V_{\max} [S]}{K_m + [S]} = \frac{100\text{ }\mu\text{M/min} \times 5.0\text{ mM}}{2.0\text{ mM} + 5.0\text{ mM}} = \frac{500}{7.0} = \mathbf{71.43\text{ }\mu\text{M/min}}$$
2. Step 2: Fractional Active Site Saturation ($\theta$):
   $$\theta = \frac{v_0}{V_{\max}} \times 100\% = \frac{71.43}{100} \times 100\% = \mathbf{71.43\%}$$
3. Step 3: Lineweaver-Burk Double Reciprocal Coordinates:
   $$\text{Slope} = \frac{K_m}{V_{\max}} = \frac{2.0}{100} = \mathbf{0.020\text{ min}}$$
   $$y\text{-intercept} = \frac{1}{V_{\max}} = \frac{1}{100} = \mathbf{0.010\text{ }\mu\text{M}^{-1}\cdot\text{min}}$$
   $$x\text{-intercept} = -\frac{1}{K_m} = -\frac{1}{2.0} = \mathbf{-0.50\text{ mM}^{-1}}$$
4. Step 4: Turnover Number ($k_{\text{cat}}$):
   $$V_{\max} = \frac{100\text{ }\mu\text{M/min}}{60} = 1.6667\text{ }\mu\text{M/s}$$
   $$k_{\text{cat}} = \frac{V_{\max}}{[E]_T} = \frac{1.6667\text{ }\mu\text{M/s}}{0.5\text{ }\mu\text{M}} = \mathbf{3.33\text{ s}^{-1}}$$
5. Step 5: Catalytic Efficiency ($\frac{k_{\text{cat}}}{K_m}$):
   $$K_m = 2.0\text{ mM} = 2.0 \times 10^{-3}\text{ M}$$
   $$\text{Efficiency} = \frac{3.333\text{ s}^{-1}}{2.0 \times 10^{-3}\text{ M}} = \mathbf{1.67 \times 10^3\text{ M}^{-1}\text{s}^{-1}}$$

7. Visual Explanations & Hyperbolic Saturation

flowchart TD
    SAT_CURVE["Michaelis-Menten Hyperbolic Saturation Velocity Spectrum"]
    
    SAT_CURVE --> LOW_S["🧪 First-Order Linear Region ([S] << Km)
• Most active sites are empty ([E] >> [ES])
• Velocity scales linearly: v0 ≈ (Vmax / Km) · [S]
• Rate limited by substrate collision frequency"]
    SAT_CURVE --> MID_S["⚖️ Transition Region ([S] = Km)
• Exactly 50% of enzyme active sites are occupied (θ = 50%)
• Reaction velocity is half-maximal: v0 = Vmax / 2
• Defines substrate affinity threshold"]
    SAT_CURVE --> HIGH_S["⚡ Zero-Order Plateau Region ([S] >> Km)
• 100% active site saturation ([ES] ≈ [E]total)
• Maximum catalytic velocity: v0 ≈ Vmax
• Rate limited strictly by catalytic turnover (kcat)"]

8. Comparative & Standards Tables

8.1 Kinetic Constants of Representative Metabolic Enzymes

8.2 Diagnostic Enzyme Inhibition Comparison

9. Practical Real-World Applications

Example 1: Emergency Toxicology — Methanol Poisoning Antidote (Ethanol Infusion)

Alcohol Dehydrogenase ($\text{ADH}$) oxidizes toxic Methanol ($K_m = 7.0\text{ mM}$) into blinding Formaldehyde and Formic Acid. Infusing Ethanol ($K_m = 0.45\text{ mM}$, $15.5\times\text{ higher affinity}$) competitively displaces methanol from ADH active sites, allowing intact methanol to be safely excreted via the kidneys.

Example 2: Statin Cardiovascular Therapeutics (HMG-CoA Reductase)

Statins (Atorvastatin, Rosuvastatin) act as competitive transition-state analogs of HMG-CoA reductase with sub-nanomolar affinity ($K_i = 8.2\text{ nM}$), suppressing hepatic mevalonate production and lowering serum LDL cholesterol by 50%.

Example 3: Oncology Antimetabolite Chemotherapy (Methotrexate)

Methotrexate is a competitive inhibitor of Dihydrofolate Reductase ($\text{DHFR}$), binding with $1,000\times$ higher affinity than natural folic acid, starving rapidly dividing leukemia cells of tetrahydrofolate needed for thymidine DNA synthesis.

10. In-Depth Case Studies

Case Study 1: Clinical Toxicology — Alcohol Dehydrogenase Competitive Inhibition in Methanol Poisoning

• Clinical Presentation: A $38\text{-year-old}$ male presents to the emergency department $14\text{ hours}$ after consuming $50\text{ mL}$ of bootleg liquor. He complains of "snowstorm" blurred vision, nausea, and severe metabolic acidosis (anion gap $= 28\text{ mEq/L}$, blood $\text{pH} = 7.15$).

• Enzyme Kinetic Profile for Hepatic Alcohol Dehydrogenase (ADH):
  - Methanol: $K_m = \mathbf{7.0\text{ mM}}$ (Weak affinity; oxidized into toxic formaldehyde and formic acid).
  - Ethanol: $K_m = \mathbf{0.45\text{ mM}}$ (Strong affinity; $15.5\times\text{ higher affinity}$ than methanol).

• Therapeutic Intervention & Kinetic Mechanism:
  - Emergency physician initiates an IV infusion of Ethanol targeting a steady blood concentration of $[I] = 22\text{ mM}$ ($100\text{ mg/dL}$).
  - Apparent Methanol $K_m$ under Ethanol Inhibition:
  $$\alpha = 1 + \frac{[I]}{K_i} = 1 + \frac{22\text{ mM}}{0.45\text{ mM}} = \mathbf{49.89}$$
  $$K_m^{\text{app}} = K_m \times \alpha = 7.0\text{ mM} \times 49.89 = \mathbf{349.2\text{ mM}}$$

• Clinical Outcome: Ethanol occupied 98.2% of ADH active sites. Methanol oxidation to formic acid dropped by $>98\%$, preventing retinal cytochrome oxidase poisoning. The patient underwent hemodialysis and was discharged with zero permanent visual loss.

Case Study 2: Pharmacology — Statin Competitive Inhibition of HMG-CoA Reductase

• Pathology: A $58\text{-year-old}$ male with familial hypercholesterolemia has a baseline LDL-C of $210\text{ mg/dL}$.

• Target Enzyme Kinetics:
  - Hepatic HMG-CoA Reductase catalyses: $\text{HMG-CoA} + 2\text{ NADPH} \rightarrow \text{Mevalonate}$ (Rate-limiting step).
  - Natural Substrate: $K_m = 4.0\text{ }\mu\text{M}$, $V_{\max} = 120\text{ nmol/min/mg}$.
  - Baseline rate at physiological $[S] = 4.0\text{ }\mu\text{M}$: $v_0 = \frac{120 \times 4}{4 + 4} = \mathbf{60.0\text{ nmol/min/mg}}$ (50% $V_{\max}$).

• Pharmacological Intervention: Patient prescribed Atorvastatin ($20\text{ mg/day}$), achieving a steady-state hepatic concentration of $[I] = 190\text{ nM}$ ($0.19\text{ }\mu\text{M}$).
  - Inhibitor Constant: $K_i = 8.2\text{ nM} = 0.0082\text{ }\mu\text{M}$.
  - Apparent Substrate Affinity Constant:
  $$K_m^{\text{app}} = 4.0\text{ }\mu\text{M} \times \left(1 + \frac{0.19}{0.0082}\right) = 4.0 \times 24.17 = \mathbf{96.68\text{ }\mu\text{M}}$$
  - Inhibited Velocity:
  $$v_0 = \frac{120 \times 4.0}{96.68 + 4.0} = \mathbf{4.77\text{ nmol/min/mg}} \quad (\mathbf{92.05\%\text{ reduction in mevalonate synthesis}})$$

• Therapeutic Outcome: Decreased intracellular cholesterol stimulated SREBP-2 transcription, increasing hepatocyte cell-surface LDL receptor density and dropping plasma LDL-C to $98\text{ mg/dL}$.

11. Advantages of Michaelis-Menten Kinetic Modeling

1. Quantifies Drug Potency ($K_i$): Determines the exact concentration required to inhibit target disease pathways.
2. Defines Physiological Enzyme Capacity: Explains metabolic flux rates under varying dietary or pathological conditions.
3. Linearizes Complex Non-Linear Curves: Lineweaver-Burk, Eadie-Hofstee, and Hanes-Woolf transformations simplify parameter extraction.
4. Guides Protein Engineering: Identifies mutations that optimize $k_{\text{cat}}/K_m$ for industrial biocatalysts.

12. Methodological Complexities & Artifacts

1. Substrate Depletion Artifacts: If more than 10% of initial substrate is consumed during the assay, the measured rate no longer reflects true initial velocity ($v_0$), underestimating $V_{\max}$.
2. High-Substrate Inhibition: At extreme substrate concentrations, two substrate molecules can bind non-productively to the active site ($ESS\text{ complex}$), causing velocity to decline rather than plateau.
3. Allosteric Cooperativity (Sigmoidal Kinetics): Multi-subunit enzymes (e.g., Aspartate Transcarbamoylase, Phosphofructokinase) exhibit sigmoidal Hill kinetics ($v_0 = \frac{V_{\max} [S]^h}{K_{0.5}^h + [S]^h}$) and cannot be fit by standard hyperbolic Michaelis-Menten equations.

13. Common Mistakes to Avoid

12. Frequently Asked Questions (FAQ)

What does the Michaelis constant ($K_m$) physically represent?

$K_m$ is the specific substrate concentration at which the enzyme operates at exactly half its maximum catalytic velocity ($v_0 = \frac{V_{\max}}{2}$). It is a quantitative indicator of enzyme-substrate binding affinity.

What is the difference between $V_{\max}$ and $k_{\text{cat}}$?

$V_{\max}$ is the maximum reaction velocity observed in a specific test tube, which increases if you add more enzyme. $k_{\text{cat}}$ (turnover number) is the intrinsic speed of an individual active site (molecules converted per second), which is independent of enzyme concentration.

How does a competitive inhibitor affect $K_m$ and $V_{\max}$?

A competitive inhibitor binds directly to the active site, increasing the apparent $K_m$ (requiring more substrate to reach half-speed), but leaves $V_{\max}$ unchanged because sufficiently high substrate concentrations displace the inhibitor.

Why do Lineweaver-Burk plots intersect on the y-axis during competitive inhibition?

Because competitive inhibitors do not change $V_{\max}$, the reciprocal maximum velocity ($\frac{1}{V_{\max}}$) is identical, causing all inhibited and uninhibited lines to intersect at the exact same $y\text{-intercept}$.

What is "Catalytic Perfection"?

An enzyme is said to have achieved catalytic perfection when its catalytic efficiency ($\frac{k_{\text{cat}}}{K_m}$) approaches $10^8\text{-}10^9\text{ M}^{-1}\text{s}^{-1}$. At this point, the enzyme turns over substrate as rapidly as the molecules can physically diffuse into the active site.

How do you measure initial velocity ($v_0$) experimentally?

By measuring product formation (or substrate consumption) using spectrophotometry, fluorescence, or chromatography within the first $30\text{-}60\text{ seconds}$ of the reaction, ensuring less than $5\text{-}10\%$ of substrate has been consumed.

What is the difference between non-competitive and uncompetitive inhibition?

Non-competitive inhibitors bind to an allosteric site on both the free enzyme ($E$) and the complex ($ES$), decreasing $V_{\max}$ without altering $K_m$. Uncompetitive inhibitors bind exclusively to the $ES$ complex, decreasing both $V_{\max}$ and $K_m$ in equal proportion.

15. Expert Tips for Biochemists, Pharmacologists & Enzymologists

1. Use Non-Linear Regression Over Lineweaver-Burk for Final Parameters: While Lineweaver-Burk is ideal for visualizing inhibition modes, non-linear regression avoids unequal weighting of low substrate concentrations.
2. Ensure Substrate Concentrations Span $0.2\text{ to }10 \times K_m$: A robust kinetic dataset requires at least $8\text{-}10$ data points distributed symmetrically around the estimated $K_m$.
3. Verify Pure Initial Velocity ($<5\%$ Substrate Depletion): Always inspect the linear slope of absorbance vs. time before calculating $v_0$ to prevent product inhibition artifacts.

16. Summary Checklist

• ✔ Measure Initial Velocity ($v_0$): Record rate during linear early-phase substrate turnover.

• ✔ Span Substrate Concentrations ($[S]$): Test across $0.2 \times K_m$ to $10 \times K_m$.

• ✔ Calculate Maximum Velocity ($V_{\max}$): Determine asymptotic saturation rate.

• ✔ Solve Michaelis Constant ($K_m$): Identify $[S]$ at $v_0 = V_{\max} / 2$.

• ✔ Determine Turnover Number ($k_{\text{cat}}$): Solve $k_{\text{cat}} = V_{\max} / [E]_T \quad (\text{s}^{-1})$.

• ✔ Evaluate Catalytic Efficiency: Solve $\frac{k_{\text{cat}}}{K_m} \quad (\text{M}^{-1}\text{s}^{-1})$.

• ✔ Diagnose Inhibition Mechanism: Distinguish competitive, non-competitive, and uncompetitive profiles.